Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnér S., Meyerson B. A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 1988 Apr;33(1):11–23. doi: 10.1016/0304-3959(88)90198-4. [DOI] [PubMed] [Google Scholar]
- Bowsher D. Neurogenic pain syndromes and their management. Br Med Bull. 1991 Jul;47(3):644–666. doi: 10.1093/oxfordjournals.bmb.a072498. [DOI] [PubMed] [Google Scholar]
- Choonara I., Lawrence A., Michalkiewicz A., Bowhay A., Ratcliffe J. Morphine metabolism in neonates and infants. Br J Clin Pharmacol. 1992 Nov;34(5):434–437. doi: 10.1111/j.1365-2125.1992.tb05652.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McQuay H. J., Carroll D., Faura C. C., Gavaghan D. J., Hand C. W., Moore R. A. Oral morphine in cancer pain: influences on morphine and metabolite concentration. Clin Pharmacol Ther. 1990 Sep;48(3):236–244. doi: 10.1038/clpt.1990.145. [DOI] [PubMed] [Google Scholar]
- Morley J. S., Miles J. B., Wells J. C., Bowsher D. Paradoxical pain. Lancet. 1992 Oct 24;340(8826):1045–1045. doi: 10.1016/0140-6736(92)93067-w. [DOI] [PubMed] [Google Scholar]
- Paul D., Standifer K. M., Inturrisi C. E., Pasternak G. W. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther. 1989 Nov;251(2):477–483. [PubMed] [Google Scholar]
- Portenoy R. K., Thaler H. T., Inturrisi C. E., Friedlander-Klar H., Foley K. M. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther. 1992 Apr;51(4):422–431. doi: 10.1038/clpt.1992.42. [DOI] [PubMed] [Google Scholar]
- Smith M. T., Watt J. A., Cramond T. Morphine-3-glucuronide--a potent antagonist of morphine analgesia. Life Sci. 1990;47(6):579–585. doi: 10.1016/0024-3205(90)90619-3. [DOI] [PubMed] [Google Scholar]